These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma. Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121 [TBL] [Abstract][Full Text] [Related]
3. [(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in begnign and malignant pheochromocytomas. van der Harst E; de Herder WW; Bruining HA; Bonjer HJ; de Krijger RR; Lamberts SW; van de Meiracker AH; Boomsma F; Stijnen T; Krenning EP; Bosman FT; Kwekkeboom DJ J Clin Endocrinol Metab; 2001 Feb; 86(2):685-93. PubMed ID: 11158032 [TBL] [Abstract][Full Text] [Related]
4. The current status of radioiodinated metaiodobenzylguanidine therapy of neuro-endocrine tumors. Shapiro B; Sisson JC; Shulkin BL; Gross MD; Zempel S Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):55-7. PubMed ID: 9002750 [TBL] [Abstract][Full Text] [Related]
5. Late presentation of metastatic pheochromocytoma: a problem case solved by I-131 MIBG scintigraphy. Geatti O; Shapiro B; Virgolini L Clin Nucl Med; 1990 Feb; 15(2):101-4. PubMed ID: 1690098 [TBL] [Abstract][Full Text] [Related]
6. Metastatic phaeochromocytoma with a long-term response after iodine-131 metaiodobenzylguanidine therapy. Pujol P; Bringer J; Faurous P; Jaffiol C Eur J Nucl Med; 1995 Apr; 22(4):382-4. PubMed ID: 7607270 [TBL] [Abstract][Full Text] [Related]
7. [Therapy of malignant pheochromocytoma using I-131 metaiodobenzylguanidine--report of a case]. Okazawa H; Endo K; Saga T; Watanabe Y; Nakai T; Kasagi K; Konishi J; Abe M; Goto K; Nakao K Nihon Igaku Hoshasen Gakkai Zasshi; 1990 Mar; 50(3):286-94. PubMed ID: 2345700 [TBL] [Abstract][Full Text] [Related]
11. 131I-metaiodobenzylguanidine--a new agent for scintigraphic imaging and treatment of pheochromocytoma. Fischer M; Vetter W; Winterberg B; Vetter H Nuklearmedizin; 1984 Apr; 23(2):77-9. PubMed ID: 6473116 [TBL] [Abstract][Full Text] [Related]
12. [Nuclear medicine diagnosis and therapy of distant metastases of pheochromocytoma]. Grünwald F; Ruhlmann J; Kozak B; Overlack A; Christ F; Hotze A; Biersack HJ Dtsch Med Wochenschr; 1988 Feb; 113(8):297-9. PubMed ID: 3277832 [TBL] [Abstract][Full Text] [Related]
13. [Nuclear medical therapy of pheochromocytoma]. Fischer M; Winterberg B; Zidek W; Müller-Rensing R; Vetter H Schweiz Med Wochenschr; 1984 Dec; 114(49):1841-3. PubMed ID: 6515381 [TBL] [Abstract][Full Text] [Related]
14. Pheochromocytoma: diagnosis by scintigraphy using iodine 131 metaiodobenzylguanidine. Campeau RJ; Garcia OM; Correa OA; Rege AB South Med J; 1991 Oct; 84(10):1221-30. PubMed ID: 1925724 [TBL] [Abstract][Full Text] [Related]
15. Semiquantitative 123I-Metaiodobenzylguanidine Scintigraphy to Distinguish Pheochromocytoma and Paraganglioma from Physiologic Adrenal Uptake and Its Correlation with Genotype-Dependent Expression of Catecholamine Transporters. van Berkel A; Rao JU; Lenders JW; Pellegata NS; Kusters B; Piscaer I; Hermus AR; Plantinga TS; Langenhuijsen JF; Vriens D; Janssen MJ; Gotthardt M; Timmers HJ J Nucl Med; 2015 Jun; 56(6):839-46. PubMed ID: 25883126 [TBL] [Abstract][Full Text] [Related]
16. Effects and safety of ¹³¹I-metaiodobenzylguanidine (MIBG) radiotherapy in malignant neuroendocrine tumors: results from a multicenter observational registry. Yoshinaga K; Oriuchi N; Wakabayashi H; Tomiyama Y; Jinguji M; Higuchi T; Kayano D; Fukuoka M; Inaki A; Toratani A; Okamoto S; Shiga T; Ito YM; Nakajo M; Nakajo M; Kinuya S; ; ; Endocr J; 2014; 61(12):1171-80. PubMed ID: 25214026 [TBL] [Abstract][Full Text] [Related]
17. Repeated [131I]metaiodobenzylguanidine therapy in two patients with malignant pheochromocytoma. Lam MG; Lips CJ; Jager PL; Dullaart RP; Lentjes EG; van Rijk PP; de Klerk JM J Clin Endocrinol Metab; 2005 Oct; 90(10):5888-95. PubMed ID: 16046591 [TBL] [Abstract][Full Text] [Related]
18. [Therapeutic effectiveness of 131I-MIBG on malignant pheochromocytoma--results of long-term follow-up]. Kusakabe K; Kanaya K; Kanaya S; Yazaki E; Nakano K; Matsumoto N; Kobayashi H; Maki M; Itou Y; Obara T Kaku Igaku; 1994 Dec; 31(12):1495-502. PubMed ID: 7861648 [TBL] [Abstract][Full Text] [Related]
19. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma. Swensen SJ; Brown ML; Sheps SG; Sizemore GW; Gharib H; Grant CS; van Heerden JA Mayo Clin Proc; 1985 May; 60(5):299-304. PubMed ID: 3990377 [TBL] [Abstract][Full Text] [Related]
20. Diagnostic localization of extra-adrenal pheochromocytoma: comparison of (123)I-MIBG imaging and (131)I-MIBG imaging. Nakatani T; Hayama T; Uchida J; Nakamura K; Takemoto Y; Sugimura K Oncol Rep; 2002; 9(6):1225-7. PubMed ID: 12375024 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]